Ven­tyx seeks to rack up $176M+ in its lat­est move as the mar­ket be­come bull­ish on TYK2

Cal­i­for­nia-based biotech Ven­tyx Bio­sciences has man­aged to snap up quite a bit of cash since emerg­ing last year, and its lat­est move will hope to give the com­pa­ny an­oth­er nine-fig­ure boost.

On Mon­day, Ven­tyx an­nounced that it is look­ing to raise around $176.6 mil­lion, which will ex­tend the biotech’s cash in­to 2025. A state­ment said that the funds will be go­ing to­ward fund­ing the de­vel­op­ment of the four can­di­dates in the com­pa­ny’s pipeline, fund­ing ad­di­tion­al re­search and oth­er us­es.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER